Oncology medical news

Headlines

14 Apr 2019 - Oncology Conference reports ELCC 2019 - Many problems with accessibility to lung cancer care in low and middle income EU countries
Most health care systems in the eastern part of the EU are under financed and under equipped to deal with lung cancer
14 Apr 2019 - Oncology Conference reports ELCC 2019 - Some hints to overcoming resistance to checkpoint inhibitors
The classic complement pathway has been implicated in immunomodulation of tumors of the lung
14 Apr 2019 - Oncology Conference reports ELCC 2019 - Molecular tumor boards “bring order to chaos”
The dynamics of precision medicine are challenging and need molecular tumor boards to be harvested for the good of the patients

Latest Updates

19 Apr 2019 - Univadis Clinical Summaries from Haematologica Follicular lymphoma: 13-year data for rituximab-based frontline therapy
Complete remission is the greatest predictor of long-term survival.
19 Apr 2019 - Univadis Clinical Summaries from Jpn J Clin Oncol Tracheal cancer: database analysis suggests resection is sufficient
NCDB analysis finds no survival benefit for adjuvant radiotherapy.
19 Apr 2019 - Univadis Clinical Summaries from Lancet Respir Med ALK+ NSCLC: frontline alectinib tops crizotinib in all-Asian trial
ALESIA study confirms consistency of the global ALEX trial.
19 Apr 2019 - Univadis Clinical Summaries from Gastroenterology Colorectal polyps: underwater resection tops conventional approach
Novel randomized controlled trial of endoscopic mucosal resection techniques.
19 Apr 2019 - Univadis Clinical Summaries from Clin Cancer Res Breast cancer CNS metastases: new lapatinib strategy allows high doses
High-dose lapatinib is tolerable when alternating with capecitabine.
19 Apr 2019 - Univadis Clinical Summaries from Brachytherapy Cervical cancer: HDR brachytherapy effective with less toxicity
Similar local disease control, cancer-specific survival vs LDR brachytherapy.
19 Apr 2019 - Univadis Medical News Doxepin mouthwash for radiotherapy-related oral mucositis
Results from the Alliance A221304 randomised clinical trial.
19 Apr 2019 - Oncology guidelines update from J Clin Oncol ASCO: new oxaliplatin guidelines for stage III colon cancer
Shorter course of adjuvant chemotherapy an option for low-risk patients.
18 Apr 2019 - Medical news from National Institute for Health and Care Excellence NICE says no to osimertinib for EGFR-positive NSCLC
The NICE appraisal committee raised a number of issues concerning the clinical evidence
18 Apr 2019 - Univadis Clinical Summaries from Lancet NSCLC: pembrolizumab tops chemotherapy at lower PD-L1 cutoff
KEYNOTE-042 data led FDA to lower the PD-L1 cutoff.
18 Apr 2019 - UK Medical News Red meat within recommended limits still raises risk of colorectal cancer
Data from the UK Biobank for half a million men and women aged 40-69 years.
18 Apr 2019 - Univadis Clinical Summaries from Lancet Oncol Final analysis: abiraterone ups survival in high-risk metastatic prostate cancer
Data from the LATITUDE phase 3 trial in castration-sensitive disease.
18 Apr 2019 - Univadis Clinical Summaries from JAMA Oncol MRI criteria for "good-prognosis" patients in rectal cancer
Distinguishes who can avoid preoperative chemotherapy.
18 Apr 2019 - Univadis Clinical Summaries from J Oral Maxillofac Surg Oral cancer: comorbidity status, immune biomarkers predict survival
A severe comorbidity quadrupled mortality risk in OSCC, regardless of stage.

Related topics

You're leaving Univadis